90 related articles for article (PubMed ID: 28049950)
21. Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks.
Jefferies JM; Johnston CH; Kirkham LA; Cowan GJ; Ross KS; Smith A; Clarke SC; Brueggemann AB; George RC; Pichon B; Pluschke G; Pfluger V; Mitchell TJ
J Infect Dis; 2007 Sep; 196(6):936-44. PubMed ID: 17703426
[TBL] [Abstract][Full Text] [Related]
22. Pneumolysin induces the salient histologic features of pneumococcal infection in the rat lung in vivo.
Feldman C; Munro NC; Jeffery PK; Mitchell TJ; Andrew PW; Boulnois GJ; Guerreiro D; Rohde JA; Todd HC; Cole PJ
Am J Respir Cell Mol Biol; 1991 Nov; 5(5):416-23. PubMed ID: 1834101
[TBL] [Abstract][Full Text] [Related]
23. Sensitivities of human monocytes and epithelial cells to pneumolysin are different.
Hirst RA; Yesilkaya H; Clitheroe E; Rutman A; Dufty N; Mitchell TJ; O'Callaghan C; Andrew PW
Infect Immun; 2002 Feb; 70(2):1017-22. PubMed ID: 11796644
[TBL] [Abstract][Full Text] [Related]
24. Sequence variation in the Streptococcus pneumoniae pneumolysin gene affecting haemolytic activity and electrophoretic mobility of the toxin.
Lock RA; Zhang QY; Berry AM; Paton JC
Microb Pathog; 1996 Aug; 21(2):71-83. PubMed ID: 8844651
[TBL] [Abstract][Full Text] [Related]
25. Implication of pneumolysin as a virulence factor in Streptococcus pneumoniae endophthalmitis.
Ng EW; Samiy N; Rubins JB; Cousins FV; Ruoff KL; Baker AS; D'Amico DJ
Retina; 1997; 17(6):521-9. PubMed ID: 9428015
[TBL] [Abstract][Full Text] [Related]
26. Tumor suppressor CYLD regulates acute lung injury in lethal Streptococcus pneumoniae infections.
Lim JH; Stirling B; Derry J; Koga T; Jono H; Woo CH; Xu H; Bourne P; Ha UH; Ishinaga H; Xu H; Andalibi A; Feng XH; Zhu H; Huang Y; Zhang W; Weng X; Yan C; Yin Z; Briles DE; Davis RJ; Flavell RA; Li JD
Immunity; 2007 Aug; 27(2):349-60. PubMed ID: 17723219
[TBL] [Abstract][Full Text] [Related]
27. Detection of pneumolysin and autolysin genes among antibiotic resistant Streptococcus pneumoniae in invasive infections.
Sourav S; Patricia A; Sharma S; Kanungo R; Jayachandran S; Prashanth K
Indian J Med Microbiol; 2010; 28(1):34-9. PubMed ID: 20061761
[TBL] [Abstract][Full Text] [Related]
28. Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.
Ramos-Sevillano E; Urzainqui A; Campuzano S; Moscoso M; González-Camacho F; Domenech M; Rodríguez de Córdoba S; Sánchez-Madrid F; Brown JS; García E; Yuste J
Infect Immun; 2015 Feb; 83(2):591-603. PubMed ID: 25404032
[TBL] [Abstract][Full Text] [Related]
29. Pneumolysin as a potential therapeutic target in severe pneumococcal disease.
Anderson R; Feldman C
J Infect; 2017 Jun; 74(6):527-544. PubMed ID: 28322888
[TBL] [Abstract][Full Text] [Related]
30. Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.
Marquart ME; Monds KS; McCormick CC; Dixon SN; Sanders ME; Reed JM; McDaniel LS; Caballero AR; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2661-6. PubMed ID: 17525197
[TBL] [Abstract][Full Text] [Related]
31. Real-time pneumolysin polymerase chain reaction with melting curve analysis differentiates pneumococcus from other alpha-hemolytic streptococci.
Kaijalainen T; Saukkoriipi A; Bloigu A; Herva E; Leinonen M
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):293-9. PubMed ID: 16360553
[TBL] [Abstract][Full Text] [Related]
32. The hemolytic and complement-activating properties of pneumolysin do not contribute individually to virulence in a pneumococcal bacteremia model.
Benton KA; Paton JC; Briles DE
Microb Pathog; 1997 Oct; 23(4):201-9. PubMed ID: 9344781
[TBL] [Abstract][Full Text] [Related]
33. Shionone-Targeted Pneumolysin to Ameliorate Acute Lung Injury Induced by
Du R; Wang T; Lv H; Zou Y; Hou X; Hou N; Zhang P; Li H; Chi G
Molecules; 2022 Sep; 27(19):. PubMed ID: 36234795
[No Abstract] [Full Text] [Related]
34. Roles of interleukin-6 and macrophage inflammatory protein-2 in pneumolysin-induced lung inflammation in mice.
Rijneveld AW; van den Dobbelsteen GP; Florquin S; Standiford TJ; Speelman P; van Alphen L; van der Poll T
J Infect Dis; 2002 Jan; 185(1):123-6. PubMed ID: 11756992
[TBL] [Abstract][Full Text] [Related]
35. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.
García-Suárez Mdel M; Cima-Cabal MD; Flórez N; García P; Cernuda-Cernuda R; Astudillo A; Vázquez F; De los Toyos JR; Méndez FJ
Infect Immun; 2004 Aug; 72(8):4534-40. PubMed ID: 15271913
[TBL] [Abstract][Full Text] [Related]
36. Anti-pneumolysin activity of commercially available alpha 1-antitrypsin is due to cholesterol impurities.
Rubins JB; Freiberg MR
Microb Pathog; 1994 Mar; 16(3):221-8. PubMed ID: 8090079
[TBL] [Abstract][Full Text] [Related]
37. In vitro expression of Streptococcus pneumoniae ply gene in human monocytes and pneumocytes.
Hu DK; Liu Y; Li XY; Qu Y
Eur J Med Res; 2015 May; 20(1):52. PubMed ID: 25943628
[TBL] [Abstract][Full Text] [Related]
38. Pneumococcal sialidase promotes bacterial survival by fine-tuning of pneumolysin-mediated membrane disruption.
Shizukuishi S; Ogawa M; Kuroda E; Hamaguchi S; Sakuma C; Kakuta S; Tanida I; Uchiyama Y; Akeda Y; Ryo A; Ohnishi M
Cell Rep; 2024 Mar; 43(3):113962. PubMed ID: 38483905
[TBL] [Abstract][Full Text] [Related]
39. Streptococcus pneumoniae produces a second haemolysin that is distinct from pneumolysin.
Canvin JR; Paton JC; Boulnois GJ; Andrew PW; Mitchell TJ
Microb Pathog; 1997 Mar; 22(3):129-32. PubMed ID: 9075215
[TBL] [Abstract][Full Text] [Related]
40. Human lung mast cells mediate pneumococcal cell death in response to activation by pneumolysin.
Cruse G; Fernandes VE; de Salort J; Pankhania D; Marinas MS; Brewin H; Andrew PW; Bradding P; Kadioglu A
J Immunol; 2010 Jun; 184(12):7108-15. PubMed ID: 20483738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
